Drug Treatments T2D Flashcards

1
Q

Sulfonylureas

  • properties
  • examples
  • side effects
A

-all bound to plasma proteins so longer half life
-all orally active
E.g. glipizide, gliclazide

Major Side Effect:
-Hypoglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sulfonylureas
-MOA
primary + secondary

A

stimulates endogenous insulin release
-binds to ATP sensitive K channel to promote insulin secretion

secondary

  • Sensitize ß-cells to glucose
  • Decrease lipolysis
  • Decrease clearance of insulin by the liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Biguanide drugs

-MOA

A

1) Increase glucose uptake in muscle
- increased GLUT4 translocation through AMPK
increases insulin sensitivity

2) Decrease glucose production by liver through AMPK and gene expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Thiazolidinediones

Example
MOA

side effects:

A

E.G Pioglitazone

can reduce the effectiveness of OCP

This is the only one that is approved

Activate peroxisome proliferator-activated receptor-g (PPARg)

increases insulin sensitivity

adverse effects: weight gain, fluid retention, subject to interactions due to liver metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Glucagon-like peptide-1 analogs

Give Example

A

sc injection
facilitates glucose control
promotes satiety
augments pancreas response

E.g. Exenatide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

DPP IV inhibitors

  • vildagliptin (reversible)
  • sitagliptin (reversible)
  • saxagliptin (covalently bound)
A

e. g.
- vildagliptin (reversible)
- sitagliptin (reversible)
- saxagliptin (covalently bound)

oral hypoglycaemic agents

increased levels of incretins GLP-1 and GIP

cancer risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

SGLT 2

A

High capacity
Low affinity

inhibit glucose transporter in small intestine and proximal straight tubule(90% glucose absorption occurs here)

Dapagliflozin
Canagliflozin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SGLT 1

A

Low capacity
High affinity

found in proximal convulated tubule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Effects of SGLT2 Inhibitors

A
  • Increased insulin sensitivity in muscle
  • increased insulin sensitivity in liver
  • improved beta cell function
  • decreased gluconeogenesis

side effects- weight loss, dehydration, can worsen UTI and thrush

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Insulin

-Hepatic effects

A

Increases glycogenesis

Inhibits

  • gluconeogenesis
  • glycogenolysis
  • ketogenesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Insulin

-Skeletal muscle effects

A

increases GLUT 4 translocation=more glucose uptake
increases glucose oxidation, glycogenesis, amino acid uptake, protein synthesis

Decreases:
Glycogenolysis
amino acid release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Therapeutic uses

of sulfonylureas

A

best patient is
over 40 yrs. old
DM duration less than 10 yrs.
daily insulin (if taking) less than 40 units

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Properties of metformin

A
  • orally active
  • does not bind to plasma protein
  • excreted unchanged in urine
  • also used for PCOS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Glitazones (thiazolidinediones)

A

Activate peroxisome proliferator-activated receptor-g (PPARg)
PPARs involved in transcription of insulin-responsive genes and in regulation of adipocyte lipid metabolism

orally active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

4 causes of hyperglycaemia

A

Insulin resistance

B cell dysfunction

Loss of B cell mass

SGLT2 Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Properties of metformin

A

orally active
does not bind plasma proteins
excreted unchanged in urine
can be combined

17
Q

What class does exenatide belong to?

A

GLP 1 analog

Glucagon-like peptide-1 analogs

18
Q

DDP 4 inhibitors

given an example

A

orally active
cancer risk
few side effects
so GI side effects

increased levels of Incretins GLP-1 and GIP

-sitagliptin